GG5 T3b N1Mx stage 4 PCa. What germline or somatic tests should I get? De novo

December 3, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Testing for Your Prostate Cancer Stage

I appreciate you sharing your staging information. Let me help you understand the types of genetic testing that oncologists typically consider for advanced prostate cancer, and then we'll focus on questions to ask your care team about YOUR specific situation.

General Testing Approach for Advanced Prostate Cancer

According to NCCN Guidelines for Prostate Cancer, when patients present with advanced disease (stage 4), oncologists typically evaluate:

Somatic Testing (tumor DNA)

  • Mismatch Repair (MMR) deficiency - helps determine immunotherapy eligibility
  • BRCA1/BRCA2 mutations - may influence treatment selection and prognosis
  • PTEN loss - associated with more aggressive disease
  • TP53 mutations - prognostic significance
  • Microsatellite Instability (MSI) - relevant for immunotherapy consideration

Germline Testing (inherited DNA)

  • BRCA1/BRCA2 - important for family planning and may influence treatment decisions
  • Lynch syndrome genes - if MMR deficiency is found
  • Other DNA repair genes (CHEK2, PALB2, ATM) - emerging significance in prostate cancer

Why this matters: These tests help oncologists understand your tumor's biology and may open access to targeted therapies or clinical trials.


Important: Your Doctor Determines What's Right for YOU

However, YOUR specific situation requires your oncologist's evaluation. The decision about which tests to pursue depends on:

  • Your complete pathology report
  • Your treatment goals
  • Your family history
  • Available treatment options at your center

Questions to Ask Your Oncology Team

  1. "Based on my stage 4 prostate cancer diagnosis, which genetic tests do you recommend for me—both somatic (tumor) and germline (inherited)?"

  2. "How will the results of these tests affect my treatment options or eligibility for clinical trials?"

  3. "If I have BRCA mutations or other DNA repair gene mutations, what does that mean for my treatment and my family members?"

  4. "Are there any clinical trials I might be eligible for based on my tumor genetics?"

  5. "What is the timeline for getting these tests done, and when will we have results?"


Authoritative Resources

  • NCCN Guidelines for Prostate Cancer - comprehensive recommendations for genetic testing in advanced disease
  • American Cancer Society - information on genetic testing for prostate cancer
  • National Cancer Institute (NCI) - resources on somatic and germline testing

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2